Lv1
90 积分 2026-02-06 加入
The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9
2个月前
已关闭
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
2个月前
已完结
Impact of pre-infusion disease burden on outcomes in pediatric relapsed/refractory B-cell lymphoblastic leukemia following anti-CD19 CAR T-cell therapy
2个月前
已完结
Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study
2个月前
已完结
ZUMA-8: a phase 1 study of brexucabtagene autoleucel in patients with relapsed/refractory chronic lymphocytic leukemia
2个月前
已完结
CD22-Directed CAR T-Cell Therapy Mediates Durable Complete Responses in Adults with Relapsed or Refractory Large B-Cell Lymphoma after Failure of CD19-Directed CAR T-Cell Therapy and High Response Rates in Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
2个月前
已关闭
Biology and therapeutic potential of extracellular vesicle targeting and uptake
3个月前
已完结
Advancing cell and gene therapy: Application of AI/ML in clinical development and patient management
4个月前
已完结
De novo design of small molecule–regulated protein oligomers
4个月前
已完结
Engineering challenges and translational opportunities in emerging gene delivery platforms
4个月前
已完结
皖公网安备34019202002308
